iCRT 14
CAS No. 677331-12-3
iCRT 14 ( iCRT14 | iCRT-14 | iCRT 14 | Wnt inhibitor )
产品货号. M18982 CAS No. 677331-12-3
iCRT 14 是一种新型有效的 β-连环蛋白响应转录 (CRT) 抑制剂(在 Wnt 通路活性测定中,IC50= 40.3 nM)。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥282 | 有现货 |
|
| 5MG | ¥471 | 有现货 |
|
| 10MG | ¥708 | 有现货 |
|
| 25MG | ¥1144 | 有现货 |
|
| 50MG | ¥1841 | 有现货 |
|
| 100MG | ¥3357 | 有现货 |
|
| 500MG | ¥7065 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥519 | 有现货 |
|
生物学信息
-
产品名称iCRT 14
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述iCRT 14 是一种新型有效的 β-连环蛋白响应转录 (CRT) 抑制剂(在 Wnt 通路活性测定中,IC50= 40.3 nM)。
-
产品描述iCRT14 is a potent inhibitor of β-catenin-responsive transcription (CRT) that inhibits Wnt signaling in a reporter assay in vitro (IC50 = 40.3 nM). It inhibits the interaction between β-catenin and T cell factor 4 (Tcf4) in quantitative reporter assays of β-catenin/Tcf4 binding (Ki = 53.51 μM).
-
体外实验——
-
体内实验——
-
同义词iCRT14 | iCRT-14 | iCRT 14 | Wnt inhibitor
-
通路Others
-
靶点Other Targets
-
受体Wnt
-
研究领域Cancer
-
适应症——
化学信息
-
CAS Number677331-12-3
-
分子量375.44
-
分子式C21H17N3O2S
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 29 mg/mL; 77.24 mM
-
SMILESO=C4S\C(=C/c2cc(C)n(c1cccnc1)c2C)C(=O)N4c3ccccc3
-
化学全称5-[[2,5-dimethyl-1-(3-pyridinyl)-1H-pyrrol-3-yl]methylene]-3-phenyl-2,4-thiazolidinedione
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Gonsalves FC, et al. Proc Natl Acad Sci USA. 2011 Apr 12;108(15):5954-63.
产品手册
关联产品
-
Amylin, amide, human
Amylin, a 37-amino acid polypeptide that is structurally related to calcitonin, is secreted from the B cells of the pancreas. Amylin has anoretic effects in rats. Amylin may be responsible for the etiology of insulin resistance of type II diabetes mellitus through its modulation of peripheral effects of insulin.
-
(Trp11)-Neurotensin
(Trp11)-Neurotensin
-
Gimeracil
二氢嘧啶脱氢酶抑制剂,可降解血液中的嘧啶,包括 5-氟尿嘧啶。
021-51111890
购物车()
sales@molnova.cn

